Key Takeaways
- Astera Labs shares surged approximately 11% Friday amid speculation the company will join the S&P 500 during the September 21 quarterly rebalancing.
- Bloom Energy experienced a similar 7% gain driven by comparable S&P 500 addition expectations.
- The semiconductor company delivered Q2 2026 revenue of $392.4 million, marking a 104% year-over-year increase, while adjusted EPS of $0.80 exceeded the $0.69 consensus.
- Management’s Q3 revenue forecast of $540 million to $560 million suggests approximately 40% quarter-over-quarter expansion.
- Several Wall Street firms boosted their price targets, with Citi at $430, Roth Capital reaching $450, and Northland initiating Outperform coverage at $350.
Astera Labs (ALAB) shares rallied approximately 11% Friday, climbing from around $282 as market participants wagered on the company’s potential inclusion in the S&P 500 index this month.
Astera Labs, Inc. Common Stock, ALAB
The benchmark index’s quarterly reconstitution is scheduled for September 21. Announcements regarding constituent changes typically arrive after Friday’s closing bell. Anticipating this development, traders have been accumulating ALAB shares ahead of potential confirmation.
Bloom Energy (BE) similarly benefited from S&P 500 speculation, climbing roughly 7% on the same theme. With a market capitalization exceeding $63 billion, Bloom Energy presents a compelling candidate from a size perspective.
ALAB currently commands a market cap near $47.6 billion. This valuation exceeds the S&P 500’s present minimum requirement of $22.7 billion, positioning the company as a credible contender for index entry.
Index inclusion triggers mandatory purchases by passive investment vehicles tracking the benchmark. Approximately 30% of S&P 500 assets reside in passive strategies, generating substantial automatic demand for newly added securities. This mechanical buying pressure frequently elevates stock prices even before official confirmation.
Barron’s identified additional potential candidates including Cheniere Energy (LNG), Everpure (P), Credo Technology (CRDO), Heico (HEI), Rocket (RKT), and Royalty Pharma (RPRX). SpaceX (SPCX) was excluded from consideration, having not satisfied the 12-month public trading requirement.
Accommodating new constituents necessitates removing existing members, typically those with the smallest market capitalizations. Current bottom-tier names include Trade Desk (TTD), Builders FirstSource (BLDR), Norwegian Cruise Line (NCLH), Molson Coors (TAP), and Mosaic (MOS).
Exceptional Quarterly Results Provide Additional Momentum
Index speculation represents only part of ALAB‘s upward trajectory. The company recently unveiled Q2 2026 financial results that exceeded expectations across key metrics.
Quarterly revenue reached $392.4 million, representing a 104% year-over-year expansion. Adjusted earnings per share of $0.80 surpassed analyst projections of $0.69. These figures underscore the company’s accelerating business momentum.
Forward guidance also impressed investors. Management forecasts Q3 revenue between $540 million and $560 million, implying approximately 40% sequential growth. The company announced that Scorpio X AI fabric switches commenced volume manufacturing ahead of expectations, while PCIe 6.0 products now comprise over 50% of quarterly revenue.
Wall Street Responds with Elevated Price Objectives
Analyst community sentiment has shifted decidedly bullish. Citi elevated its price objective to $430. Roth Capital increased its target to $450. Northland initiated coverage with an Outperform rating and $350 price target.
The equity had declined more than 36% from its record high of $499.48 before Friday’s rally. That pullback created what many analysts viewed as an attractive entry point given the company’s robust growth trajectory.
ALAB is scheduled to participate in the Citi 2026 Global TMT Conference on September 9, potentially attracting additional institutional attention in the near term.


